Highlights
KLSE: YSPSAH (7178)       Y.S.P. SOUTHEAST ASIA HOLDING BHD MAIN : Health Care
Last Price Today's Change   Day's Range   Trading Volume
2.15   0.00 (0.00%)  2.12 - 2.15  26,400
Analyze this stock with MQ Trader system

Financials


Market Cap: 303 Million

Market Cap 303 Million
NOSH 141 Million

Latest Audited Result:  31-Dec-2019

Latest Audited Result: 31-Dec-2019
Announcement Date 29-May-2020
Next Audited Result: 31-Dec-2020
Est. Ann. Date: 29-May-2021
Est. Ann. Due Date: 29-Jun-2021

Latest Quarter:  30-Sep-2020 [#3]

Latest Quarter: 30-Sep-2020 [#3]
Announcement Date 30-Nov-2020
Next Quarter: 31-Dec-2020
Est. Ann. Date: 25-Feb-2021
Est. Ann. Due Date: 01-Mar-2021
QoQ | YoY   -97.79%  |    -96.76%

Annual (Unaudited) ( EPS: 16.35, P/E: 13.15 )

Revenue | NP to SH 295,619  |  23,012
RPS | P/RPS 210.01 Cent  |  1.02
EPS | P/E | EY 16.35 Cent  |  13.15  |  7.60%
DPS | DY | Payout % 8.43 Cent  |  3.92%  |  51.56%
NAPS | P/NAPS 2.33  |  0.92
YoY   -24.18%
NP Margin | ROE 7.60%  |  7.02%
F.Y. | Ann. Date 31-Dec-2019  |  25-Feb-2020

T4Q Result ( EPS: 15.30, P/E: 14.05 )

Revenue | NP to SH 298,135  |  21,542
RPS | P/RPS 211.80 Cent  |  1.02
EPS | P/E | EY 15.30 Cent  |  14.05  |  7.12%
DPS | DY | Payout % 7.94 Cent  |  3.69%  |  51.90%
NAPS | P/NAPS 2.39  |  0.90
QoQ | YoY   -26.52%  |    -17.36%
NP Margin | ROE 7.25%  |  6.39%
F.Y. | Ann. Date 30-Sep-2020  |  30-Nov-2020

Annualized Result ( EPS: 16.82, P/E: 12.78 )

Revenue | NP to SH 294,692  |  23,673
RPS | P/RPS 209.35 Cent  |  1.03
EPS | P/E | EY 16.82 Cent  |  12.78  |  7.82%
DPS | DY | Payout % -
NAPS | P/NAPS -
QoQ | YoY   -32.34%  |    -7.65%
NP Margin | ROE 8.14%  |  7.02%
F.Y. | Ann. Date 30-Sep-2020  |  30-Nov-2020



Business Performance

Business Performance (By Quarter)

Trailing 4 Quarters Trailing 8 Quarters
Available Quarters 4 Quarters 8 Quarters
Continuous Quarters Of Revenue Growth 1 / 4 25.00% 1 / 8 12.50%
Total Positive Profit Years 4 / 4 100.00% 8 / 8 100.00%
Continuous Quarters Of Positive Profit 4 / 4 100.00% 8 / 8 100.00%
Continuous Quarters Of Profit Growth 0 / 4 0.00% 0 / 8 0.00%
Continuous Quarters Of Adjusted EPS Growth 0 / 4 0.00% 0 / 8 0.00%
Total Dividend Years 1 / 4 25.00% 2 / 8 25.00%
Continuous Quarters Of Dividend 0 / 4 0.00% 0 / 8 0.00%
Continuous Quarters Of Dividend Growth 0 / 4 0.00% 0 / 8 0.00%
Continuous Quarters Of Adjusted Dps Growth 0 / 4 0.00% 0 / 8 0.00%
Average ROE 1.62% 1.83%
Average Net Profit Margin 7.48% 8.08%

Business Performance (By Year)

Last 5 Financial Years Last 10 Financial Years
Available Years 5 Years 10 Years
Continuous Years Of Revenue Growth 5 / 5 100.00% 10 / 10 100.00%
Total Positive Profit Years 5 / 5 100.00% 10 / 10 100.00%
Continuous Years Of Positive Profit 5 / 5 100.00% 10 / 10 100.00%
Continuous Years Of Profit Growth 0 / 5 0.00% 0 / 10 0.00%
Continuous Years Of Adjusted EPS Growth 0 / 5 0.00% 0 / 10 0.00%
Total Dividend Years 5 / 5 100.00% 6 / 10 60.00%
Continuous Years Of Dividend 5 / 5 100.00% 6 / 10 60.00%
Continuous Years Of Dividend Growth 1 / 5 20.00% 1 / 10 10.00%
Continuous Years Of Adjusted Dps Growth 1 / 5 20.00% 1 / 10 10.00%
Average ROE 9.00% 8.11%
Average Net Profit Margin 10.13% 9.44%

Key Result

Key Result

T4Q Annualized Annual (Unaudited) Last 10 FY Average Last 5 FY Average
Revenue 298,135 294,692 295,619 217,484 261,184
NP to SH 21,542 23,673 23,012 20,415 26,061
Dividend 11,179 14,982 11,864 6,128 10,527
Adjusted EPS 15.30 16.82 16.35 14.50 18.52
Adjusted DPS 7.94 10.64 8.43 4.35 7.48

NP to SH = Net Profit Attributable to Shareholder, EPS = Earning Per Share, DPS = Dividend Per Share

All figures in '000 unless specified.

EPS & DPS's figures in Cent.


Growth

Growth (By Quarter)

LQ QoQ LQ YoY CQ YoY LQ vs Average of T4Q LQ vs Average of T8Q
Revenue 7.42% -1.91% 1.15% -2.39% -1.80%
NP to Owner -97.79% -96.76% -7.65% -95.17% -95.63%
Dividend 0.00% 0.00% -5.29% 0.00% 0.00%
Adj. EPS -97.79% -96.76% -7.65% -95.17% -95.63%
Adj. DPS 0.00% 0.00% -5.29% 0.00% 0.00%

LQ = Latest Quarter, CQ = Cumulative Quarter, T4Q = Trailing 4 Quarters, T8Q = Trailing 8 Quarters, QoQ = Quarter on Quarter, YoY = Year on Year

Growth (By Year)

T4Q vs LFY T4Q vs AL5FY T4Q vs AL10FY AQR vs LFY AQR vs AL5FY AQR vs AL10FY LFY YoY LFY vs AL5FY LFY vs AL10FY
Revenue 0.85% 14.15% 37.08% -0.31% 12.83% 35.50% 2.38% 13.18% 35.93%
NP to Owner -6.39% -17.34% 5.52% 2.87% -9.16% 15.96% -24.18% -11.70% 12.72%
Dividend -5.78% 6.19% 82.42% - % - % - % 22.58% 12.70% 93.61%
Adj. EPS -6.39% -17.34% 5.52% 2.87% -9.16% 15.96% -24.18% -11.70% 12.72%
Adj. DPS -5.78% 6.19% 82.42% - % - % - % 22.58% 12.70% 93.61%

T4Q = Trailing 4 Quarters, T8Q = Trailing 8 Quarters, AL5FY = Average of Last 5 Financial Years, AL10FY = Average of Last 10 Financial Years, LFY = Latest Financial Year AQR = Annualized Quarter Result, YoY = Year on Year

Trade this stock for as low as 0.05% brokerage. Find out more.
  5 people like this.
 
chshzhd bravo
05/08/2020 12:25 PM
SS13 Moving up
05/08/2020 2:48 PM
SS13 Can break RM2.80 today?
05/08/2020 3:56 PM
SS13 Strong buying today to close at RM2.80
05/08/2020 6:09 PM
charlietan89 Finally, YSPSAH, warmed Up and ready to go fly like other Pharma stocks!
06/08/2020 1:00 AM
SS13 Will RM3 be in sight today. Watch this space.
06/08/2020 8:51 AM
SS13 Tank empty at RM2.90
06/08/2020 11:23 AM
chshzhd even 3.50 pe only 20 with 3% dy .. what a gem of pharmacy .
07/08/2020 12:48 PM
pinetree88 Got in today YSP at 2.67. Was looking at duopharma last wk but missed out at 2.7+. But saw YSP valuations seem cheaper than the duo, kontra and the rest.
10/08/2020 4:16 PM
chshzhd u r right @pinetree88
10/08/2020 9:22 PM
chshzhd buy .. in .. today ..
11/08/2020 4:25 PM
Kalaihselvan Krishnan Went in at 2.51
12/08/2020 5:52 PM
Fly888888 pharma , dpharma sudah terbang ... amboi , ysp bila kau terbang ye ... ?
13/08/2020 3:20 PM
chshzhd keep .. buying .. :)
14/08/2020 5:47 PM
hahasong 现在很多人买PWORTH股票

很便宜,0.04

值得购买!

Many people now buy PWORTH stock

Very cheap, 0.04

worth buying!
18/08/2020 9:39 AM
Fly888888 那里便宜哦????
18/08/2020 10:51 AM
chshzhd yspsah 才便宜:)
19/08/2020 5:05 PM
GorengHealthcare push push push!
24/08/2020 10:55 AM
GorengHealthcare Still very cheap compared to Pharm,DP,Kotra and AHealth...
25/08/2020 9:16 PM
chshzhd good qr .. buy ..
26/08/2020 8:55 AM
ShareNews wah...this company rich of CASH of 104mils...almost 74sen per share with low borrowings. BUY BUY BUY
26/08/2020 10:18 AM
Keyman188 As per 2019 annual report

Cash & Cash equivalent : RM 90,083,000

Less Loan & Borrowings : RM 28,831,000 + RM 9,915,000

So net cash now : RM 51,337,000


** Don't simply tembak
26/08/2020 10:22 AM
ShareNews you just c the latest QR lo...
26/08/2020 10:26 AM
Klse0314 good counter to invest no matter long term or short term, long term invest to earn dividend compared bank interest which lower now. short term invest if vaccine is available, investor favor hearth care counter
26/08/2020 11:10 AM
chshzhd no problem .. just keep ..
26/08/2020 11:46 AM
Benlee88888 Long term shares. No problem
Slowly slowly up, I like it.
26/08/2020 1:54 PM
chshzhd cheapest pharma counter with 3% div (highest among others)
27/08/2020 12:31 AM
mayongzheng https://youtu.be/eIgQAOLapj8
01/09/2020 8:54 PM
cpng 永信藥品聚焦重症感染藥物
今年營運續增6%

永信藥品聚焦發展重症感染藥物,深化自原料藥至製劑垂直整合技術能力;今年因應疫情衝擊拉高原料庫存,原料成本均上揚,全年業績仍可望拚6%成長,維持穩定成長趨勢。

永信藥品今年由於疫情關係,各國對於抗疫物資的出口已相對保守,原物料供應鏈不若以往寬鬆,為確保生產線供貨穩定,避免來自中國大陸的料缺貨,去年底已陸續將原料存量拉高35%,目前外銷市場及內銷市場約2比8,每年成長6%的目標不變,各個品項成長動能均衡。

永信為全球少數擁有生物醱酵、化學合成技術以及藥品處方快篩技術綜合型藥廠。

近年來,由於抗生素的廣泛使用而產生抗藥性細菌,對病患健康產生重大威脅。

過去由於注射型抗黴菌藥物藥價昂貴、與臨床使用上的安全性問題,限制了病患的用藥時機與療程。

永信針對感染性疾病,持續深耕發展抗感染藥物,除了早期開發的廣效型抗生素藥物、中期發展預防性黴菌感染與抗病毒藥物,近期更朝向需求日增的重症感染領域,目前已經成功開發3項產品。

其中與台微體攜手合作,掌握特殊奈米化微脂體劑型的關鍵製程,已成功量產Amphotericin B (微脂體製劑),目前正配合進行歐、美、中等大型市場的查登作業。
03/09/2020 10:02 AM
cpng Taiwanese new special medicine Silmitasertib (CX-4945) cured covid 19 in 5 days time.

http://www.senhwabiosciences.com/tw/new?cls=1491881153&guid=1599104946
03/09/2020 2:15 PM
Deskent may I know dividend 8sen when will announce?
11/09/2020 10:44 AM
chesslim Dividen 8sen already bank in to a/c at Aug. 25. 2020
11/09/2020 5:26 PM
hahasong United States vaccine failed!

The glove unit ESCERAM 0100 is about to fly!
17/09/2020 9:34 AM
50Cents Post removed. Why?
08/10/2020 1:23 AM
Flymetothemoon Post removed. Why?
14/10/2020 7:22 PM
Investsucess Trader Very good and profitable stock,resilent, one of the best.
25/10/2020 9:31 AM
chshzhd good fundamental
30/10/2020 8:47 AM
NPRA1985 Sinopharm Vaccine (linked to Kanger) is on track for full approval in November or December

“The most promising of these, developed by Wuhan-based Sinopharm, is already being given to frontline workers in the United Arab Emirates. According to Wu Guizhen, chief biosafety expert at the Chinese Center for Disease Control and Prevention, Sinopharm’s candidate is on track for full approval this month or next.”

https://www.foreignaffairs.com/articles/united-states/2020-11-05/china-winning-vaccine-race?amp=true
07/11/2020 2:29 AM
NPRA1985 China National Pharmaceutical Group Corp (SINOPHARM), a Chinese state-owned enterprise, announced on Wednesday that data from late-stage clinical trials for its Covid-19 vaccine are «BETTER THAN EXPECTED», Reuters reported.

In Morocco, Dr. Abdelhakim Yahyane, a member of the National Scientific Advisory Committee on Vaccination, told Yabiladi earier this week that vaccine trials in the country «have REACHED THE FINAL PHASE».

We are impatiently awaiting the end of this process, which could probably happen BY NEXT WEEK

https://en.yabiladi.com/articles/details/101544/conducted-morocco-among-others-sinopharm-s.html
13/11/2020 9:53 PM
Lieu888 anyone know the QR announcement?
27/11/2020 9:34 AM
Lieu888 profitable stock but share price not moving much....
27/11/2020 9:36 AM
gongkia yspsah doesnt have vacine? :)
27/11/2020 11:36 AM
oskchoon PM Muhyiddin announced free Covid-19 vaccine for all Malaysians
27/11/2020 8:04 PM
NPRA1985 PM: No call to reject 2021 Budget just to bring about polls

"There is no need to do that (reject the 2021 Budget). If you ask me, I could have yesterday advised the Yang di-Pertuan Agong Al-Sultan Abdullah Ri'ayatuddin Al-Mustafa Billah Shah, to dissolve Parliament so that a general election can be held.

"But we all know that the problem is Covid-19. InsyaAllah, if He allows it, when the pandemic is over, we can hold a general election.

Muhyiddin added that the 2021 Budget, worth RM322.5 billion which was passed at the policy level in Parliament on Thursday, is aimed at easing the burden of the people and restoring the country's economy.

"I hope the 2021 Budget will be approved at the Dewan Rakyat and subsequently at the Dewan Negara. This is to ensure that the people will receive the assistance that they need during this tough time."

https://www.nst.com.my/news/politics/2020/11/645117/pm-no-call-reject-2021-budget-just-bring-about-polls
29/11/2020 9:26 PM
NPRA1985 No significant change to reject budget at committee level: Dr M

FORMER Prime Minister (PM) Tun Dr Mahathir Mohamad said no significant change can be achieved if the proposed Budget 2021 is rejected at the committee level debate session.

“Rejecting the budget at the committee level, as it is said to be done, will not bring any significant impact on the government nor the proposed budget.

“It is just an attempt to divert the criticisms of the people who are disappointed with the attitude of the Opposition,” Dr Mahathir said in a statement today.

https://themalaysianreserve.com/2020/11/27/no-significant-change-to-reject-budget-at-committee-level-dr-m/
29/11/2020 9:36 PM
NPRA1985 UAE says Sinopharm vaccine has 86% efficacy against COVID-19

DUBAI (Reuters) - An experimental coronavirus vaccine developed by China’s Sinopharm has 86% efficacy against the virus, the United Arab Emirates health ministry said on Wednesday, citing an interim analysis of a human trial underway there.

The Gulf Arab state in July started Phase 3 clinical trials of the vaccine, developed by Beijing Institute of Biological Product, a unit of Sinopharm’s China National Biotec Group (CNBG). In September, the UAE approved its emergency use for certain groups.

The analysis also shows “99% seroconversion rate of neutralizing antibody and 100% effectiveness in preventing moderate and severe cases of the disease”, the ministry said in a statement carried by the state news agency.

“The analysis shows no serious safety concerns,” it said.

It also said it had officially registered the vaccine, without elaborating, and that 31,000 volunteers across 125 nationalities participated in the UAE trial.

https://www.reuters.com/article/health-coronavirus-emirates/update-1-uae-says-sinopharm-vaccine-has-86-efficacy-against-covid-19-idUSL1N2IP09V
09/12/2020 3:17 PM
NPRA1985 United Arab Emirates Claims China’s Sinopharm Vaccine Is 100% Effective At Preventing Moderate And Severe Covid-19

TOPLINE The experimental vaccine developed by China National Pharmaceutical Group, also known as Sinopharm, is 86% effective at preventing Covid-19 infection and 100% effective at preventing severe and moderate disease, health officials from the United Arab Emirates announced Wednesday, although with scarce detail provided about the trial.

The UAE health ministry cited an interim analysis of a late-stage clinical trial involving 31,000 volunteers as the source of its information, though neither they nor Sinopharm provided any data from the trial to validate the claims such as how many participants were infected or how many actually received the vaccine.

The ministry said “no serious safety concerns” were observed, though, again, no information on side effects was provided.

The ministry said the announcement is a “significant vote of confidence by the UAE’s health authorities in the safety and efficacy of this vaccine.”

The ministry added that it had officially registered the vaccine at the request of the manufacturer, which it says could eventually lead to the shot’s widespread authorization.

https://www.forbes.com/sites/roberthart/2020/12/09/united-arab-emirates-claims-chinas-sinopharm-vaccine-is-100-effective-at-preventing-moderate-and-severe-covid-19/?sh=2a60fb42595c
09/12/2020 10:24 PM
gongkia why so many people keep posting the same vaccine news all over the place? cannot ban them?


here we want to know whether yspsah got vaccine or not
10/12/2020 10:01 PM
andr BBB
17/12/2020 9:55 AM
gongkia finally director bot shares, just rm100k haha.
17/12/2020 11:18 PM